RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

Add to Collection
2016 Others Fist_Author_Year_PM

Full Author : ['Foley, James E', 'Bhosekar, Vaishali', 'Kawamori, Ryuzo']
Journal Title : Vascular health and risk management
Chapter : Section3
Journal Year : 2016
Cited by : Not Available

BACKGROUND: Previous work suggests that Japanese patients with type 2 diabetes mellitus (T2DM) may respond more favorably to a DPP-4 (dipeptidyl peptidase-4) inhibitor than Caucasians. We aimed to compare the efficacy of the DPP-4 inhibitor vildagliptin (.....

Keywords : ["type diabetes mellitus", "inhibitor vildagliptin reduce", "japanese patient", "great extent", "caucasian patient", "treatment"]